University Hospital Ghent
Ghent, 9000, Belgium
NCT Number: NCT00879931
Hypothesis: Corticoid treatment in cardiac surgery works renal protective.
Study design: Randomized, double blind trial in which one group of patients will receive methylprednisolone and the other group (control) will receive placebo NaCl 0.9%.
Looking for future studies?
Notify Me20 year–80 year
All sexes
Interventional
Phase 2
Ghent, 9000, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Methylprednisolone
Placebo (NaCl 0.9%)
Time frame: within 48 hours after cardiac surgery
University Hospital, Ghent
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02566525
Elective Cardiac Surgery, Inflammation
Lexington, Kentucky, United States
View Trial DetailsNCT02838524
Elective Cardiac Surgery
Toronto, Ontario, Canada
View Trial DetailsNCT02407873
Elective Cardiac Surgery
Liège, Belgium
View Trial DetailsNCT01748266
Elective Cardiac Surgery
Saint-Etienne, France
View Trial Details